After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.
Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.
A long-standing collaboration between PNNL and Oregon State University to study harmful chemicals at federally designated hazardous waste sites primarily across the Pacific Northwest has been awarded a five-year, $12.7 million grant.
A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.
The recent coronavirus pandemic shows just how quickly a deadly pathogen can sweep across the globe, killing tens of thousands in the U.S. and disrupting daily life for millions more in the span of a few months.
Sam Chatterjee, a senior operations research scientist at PNNL, was recently appointed as associate editor for the specialty section, “Water and the Built Environment” at the peer-reviewed, open access journal Frontiers in Water.
A PNNL scientist is studying the structures of the proteins on the surface of the novel coronavirus, using NMR spectroscopy to reveal information about the molecular toolkit that holds the keys to a vaccine or treatment.
Combining its strength in biological sciences and data analytics, researchers at the Department of Energy's PNNL are working to enable a quick response to a biological incident — whether intentional, accidental or natural.
The Federal Laboratory Consortium for Technology Transfer has honored three innovations at the U.S. Department of Energy’s Pacific Northwest National Laboratory.
PNNL coastal ecologist Heida Diefenderfer was a featured speaker in February at the National Academies of Sciences, Engineering, and Medicine’s Government-University-Industry Research Roundtable on policy and global affairs.
A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.
PNNL’s Juliet Homer was an invited panelist at a California Energy Commission workshop, which highlighted research on water treatment, delivery, and energy.
While it’s one small step forward for mouse research, it’s a big step forward for understanding proteins, the molecular workhorses in biological organisms.
